Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 2/20 | 0.54 |
| ▸ | F10 | P00742 | 5/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | CNR1 | P21554 | 8/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.46 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL6436827 | 0.88 | CCR2 (0.69) | CCR2F10CNR1F2 | |
| SCHEMBL6436829 | 0.85 | CCR2 (0.55) | CCR2F10POLBCNR1F2 | |
| SCHEMBL6433615 | 0.84 | CCR2 (0.58) | CCR2F10POLBCNR1MAPT | |
| Trifluoroacetic Acid SCHEMBL6433228 | 0.83 | F10 (0.72) | CCR2F10CNR1F2 | |
| SCHEMBL6432762 | 0.82 | CCR2 (0.58) | CCR2F10POLBCNR1MAPT | |
| SCHEMBL6433289 | 0.82 | NOD2 (0.67) | CCR2F10POLBMAPTTDP1 | |
| SCHEMBL6433082 | 0.82 | CCR2 (0.78) | CCR2F10F2 | |
| Trifluoroacetic Acid SCHEMBL6436624 | 0.81 | F10 (0.67) | CCR2F10CNR1F2 | |
| SCHEMBL6439399 | 0.80 | F10 (0.60) | CCR2F10POLBCNR1MAPT | |
| SCHEMBL6432920 | 0.77 | F10 (0.67) | CCR2F10POLBMAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1042287-B1 | INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA | AVENTIS PHARMA GMBH (DE) | 2005-04-20 | — | — | EP | disclosed |
| US-6337344-B1 | ANTICOAGULANTS AND ENZYME INHIBITORS FOR CARDIOVASCULAR DISORDERS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-01-08 | — | — | US | disclosed |
| EP-1042287-A1 | INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA | Aventis Pharma Deutschland GmbH (DE) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999033800-A1 | INDOLE DERIVATIVES AS INHIBITORS OR FACTOR XA | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 1999-07-08 | — | — | WO | disclosed |